Abstract: Disclosed is a method for measuring pancreatic metabolism, which is characterized by the fact that the increase in 13CO2 in the exhaled breath is determined prior to and following the intravenous application of secretin as well as prior to and following the oral application of a 13C triglyceride.
Type:
Grant
Filed:
November 10, 2003
Date of Patent:
July 27, 2010
Assignee:
INFAI Institut fur biomedizinische Analytik und NMR-Imaging GmbH